EP3934653
Aselastín sem veirueyðandi meðhöndlun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.5.2021EP published:
9.11.2022EP application number:
21727186.5
EP translation filed:
30.1.2023Grant published:
15.3.2023EPO information:
European Patent Register
Max expiry date:
27.5.2041Expiry date:
27.5.2026Next due date:
31.5.2026
Title in English:
AZELASTINE AS ANTIVIRAL TREATMENTLanguage of the patent:
English
Timeline
Today
28.5.2021EP application
9.11.2022EP Publication
30.1.2023Translation submitted
15.3.2023Registration published
27.5.2026Expires
Owner
Name:
CEBINA GmbHAddress:
Karl-Farkas-Gasse 22, 1030 Vienna, AT
Inventor
Name:
NAGY, EszterAddress:
1070 Vienna, AT
Name:
NAGY, GáborAddress:
9400 Sopron, HU
Name:
SZIJARTO, ValeriaAddress:
1160 Wien, AT
Name:
KONRAT, RobertAddress:
1040 Vienna, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
20177451Date:
29.5.2020Country:
EP
Number:
20184767Date:
8.7.2020Country:
EP
Number:
20195740Date:
11.9.2020Country:
EP
Number:
21171333Date:
29.4.2021Country:
EP
Classification
Categories:
A61K 31/55, A61P 31/14, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 11.5.2023
Expires: 27.5.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 3
Paid: 11.5.2023
Expires: 27.5.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 4
Paid: 17.5.2024
Expires: 27.5.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 5
Paid: 12.5.2025
Expires: 27.5.2026
Payer: G.H. Sigurgeirsson ehf.